Kolon Life Science Inc. announced a private placement to issue 919,120 common shares at an issue price of KRW 21,760 per share for the gross proceeds of KRW 20,000,051,200 on June 13, 2024. The transaction will include participation from returning investor Kolon Corporation. The transaction has been approved by shareholders, restricted to a hold period and is expected to close on June 20, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,750 KRW | +0.73% | -1.66% | -19.26% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
20,750 KRW | +0.73% | -1.66% | 185M | ||
15,870 KRW | -0.38% | -0.63% | 155M | ||
1st Jan change | Capi. | |
---|---|---|
-19.26% | 185M | |
+57.48% | 827B | |
-7.18% | 350B | |
+15.37% | 319B | |
+7.45% | 294B | |
+13.62% | 240B | |
+14.55% | 221B | |
-0.33% | 219B | |
+8.14% | 167B | |
-2.99% | 158B |
- Stock Market
- Equities
- A102940 Stock
- News Kolon Life Science Inc.
- Kolon Life Science Inc. announced that it expects to receive KRW 20.0000512 billion in funding from Kolon Corporation